Global Computer-aided Drug Discovery (CADD) Market Research Report 2023

Publication ID:

PB503235532

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Computer-aided Drug Discovery (CADD) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Computer-aided Drug Discovery (CADD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Computer-aided Drug Discovery (CADD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Computer-aided Drug Discovery (CADD) in Oncological Disorders is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Computer-aided Drug Discovery (CADD) include Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., ChemBio Discovery Inc., Chemical Computing Group ULC, CompChem Solutions Ltd., IBM, Kang Yusheng Information Technology Co. Ltd. and OpenEye Scientific Software Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Drug Discovery (CADD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Drug Discovery (CADD).
The Computer-aided Drug Discovery (CADD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Computer-aided Drug Discovery (CADD) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-aided Drug Discovery (CADD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
ChemBio Discovery Inc.
Chemical Computing Group ULC
CompChem Solutions Ltd.
IBM
Kang Yusheng Information Technology Co. Ltd.
OpenEye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.
Segment by Type
Structure-based Drug Design (SBDD)
Ligand-based Drug Design (LBDD)
Segment by Application
Oncological Disorders
Neurological Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-aided Drug Discovery (CADD) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer-aided Drug Discovery (CADD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Structure-based Drug Design (SBDD)
1.2.3 Ligand-based Drug Design (LBDD)
1.3 Market by Application
1.3.1 Global Computer-aided Drug Discovery (CADD) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer-aided Drug Discovery (CADD) Market Perspective (2018-2029)
2.2 Computer-aided Drug Discovery (CADD) Growth Trends by Region
2.2.1 Global Computer-aided Drug Discovery (CADD) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Computer-aided Drug Discovery (CADD) Historic Market Size by Region (2018-2023)
2.2.3 Computer-aided Drug Discovery (CADD) Forecasted Market Size by Region (2024-2029)
2.3 Computer-aided Drug Discovery (CADD) Market Dynamics
2.3.1 Computer-aided Drug Discovery (CADD) Industry Trends
2.3.2 Computer-aided Drug Discovery (CADD) Market Drivers
2.3.3 Computer-aided Drug Discovery (CADD) Market Challenges
2.3.4 Computer-aided Drug Discovery (CADD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-aided Drug Discovery (CADD) Players by Revenue
3.1.1 Global Top Computer-aided Drug Discovery (CADD) Players by Revenue (2018-2023)
3.1.2 Global Computer-aided Drug Discovery (CADD) Revenue Market Share by Players (2018-2023)
3.2 Global Computer-aided Drug Discovery (CADD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-aided Drug Discovery (CADD) Revenue
3.4 Global Computer-aided Drug Discovery (CADD) Market Concentration Ratio
3.4.1 Global Computer-aided Drug Discovery (CADD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-aided Drug Discovery (CADD) Revenue in 2022
3.5 Computer-aided Drug Discovery (CADD) Key Players Head office and Area Served
3.6 Key Players Computer-aided Drug Discovery (CADD) Product Solution and Service
3.7 Date of Enter into Computer-aided Drug Discovery (CADD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-aided Drug Discovery (CADD) Breakdown Data by Type
4.1 Global Computer-aided Drug Discovery (CADD) Historic Market Size by Type (2018-2023)
4.2 Global Computer-aided Drug Discovery (CADD) Forecasted Market Size by Type (2024-2029)
5 Computer-aided Drug Discovery (CADD) Breakdown Data by Application
5.1 Global Computer-aided Drug Discovery (CADD) Historic Market Size by Application (2018-2023)
5.2 Global Computer-aided Drug Discovery (CADD) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Computer-aided Drug Discovery (CADD) Market Size (2018-2029)
6.2 North America Computer-aided Drug Discovery (CADD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Computer-aided Drug Discovery (CADD) Market Size by Country (2018-2023)
6.4 North America Computer-aided Drug Discovery (CADD) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer-aided Drug Discovery (CADD) Market Size (2018-2029)
7.2 Europe Computer-aided Drug Discovery (CADD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Computer-aided Drug Discovery (CADD) Market Size by Country (2018-2023)
7.4 Europe Computer-aided Drug Discovery (CADD) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-aided Drug Discovery (CADD) Market Size (2018-2029)
8.2 Asia-Pacific Computer-aided Drug Discovery (CADD) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Computer-aided Drug Discovery (CADD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Computer-aided Drug Discovery (CADD) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer-aided Drug Discovery (CADD) Market Size (2018-2029)
9.2 Latin America Computer-aided Drug Discovery (CADD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Computer-aided Drug Discovery (CADD) Market Size by Country (2018-2023)
9.4 Latin America Computer-aided Drug Discovery (CADD) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-aided Drug Discovery (CADD) Market Size (2018-2029)
10.2 Middle East & Africa Computer-aided Drug Discovery (CADD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Computer-aided Drug Discovery (CADD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Computer-aided Drug Discovery (CADD) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aaranya Biosciences Pvt. Ltd.
11.1.1 Aaranya Biosciences Pvt. Ltd. Company Detail
11.1.2 Aaranya Biosciences Pvt. Ltd. Business Overview
11.1.3 Aaranya Biosciences Pvt. Ltd. Computer-aided Drug Discovery (CADD) Introduction
11.1.4 Aaranya Biosciences Pvt. Ltd. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.1.5 Aaranya Biosciences Pvt. Ltd. Recent Development
11.2 Albany Molecular Research Inc.
11.2.1 Albany Molecular Research Inc. Company Detail
11.2.2 Albany Molecular Research Inc. Business Overview
11.2.3 Albany Molecular Research Inc. Computer-aided Drug Discovery (CADD) Introduction
11.2.4 Albany Molecular Research Inc. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.2.5 Albany Molecular Research Inc. Recent Development
11.3 Charles River Laboratories International Inc.
11.3.1 Charles River Laboratories International Inc. Company Detail
11.3.2 Charles River Laboratories International Inc. Business Overview
11.3.3 Charles River Laboratories International Inc. Computer-aided Drug Discovery (CADD) Introduction
11.3.4 Charles River Laboratories International Inc. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.3.5 Charles River Laboratories International Inc. Recent Development
11.4 ChemBio Discovery Inc.
11.4.1 ChemBio Discovery Inc. Company Detail
11.4.2 ChemBio Discovery Inc. Business Overview
11.4.3 ChemBio Discovery Inc. Computer-aided Drug Discovery (CADD) Introduction
11.4.4 ChemBio Discovery Inc. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.4.5 ChemBio Discovery Inc. Recent Development
11.5 Chemical Computing Group ULC
11.5.1 Chemical Computing Group ULC Company Detail
11.5.2 Chemical Computing Group ULC Business Overview
11.5.3 Chemical Computing Group ULC Computer-aided Drug Discovery (CADD) Introduction
11.5.4 Chemical Computing Group ULC Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.5.5 Chemical Computing Group ULC Recent Development
11.6 CompChem Solutions Ltd.
11.6.1 CompChem Solutions Ltd. Company Detail
11.6.2 CompChem Solutions Ltd. Business Overview
11.6.3 CompChem Solutions Ltd. Computer-aided Drug Discovery (CADD) Introduction
11.6.4 CompChem Solutions Ltd. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.6.5 CompChem Solutions Ltd. Recent Development
11.7 IBM
11.7.1 IBM Company Detail
11.7.2 IBM Business Overview
11.7.3 IBM Computer-aided Drug Discovery (CADD) Introduction
11.7.4 IBM Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.7.5 IBM Recent Development
11.8 Kang Yusheng Information Technology Co. Ltd.
11.8.1 Kang Yusheng Information Technology Co. Ltd. Company Detail
11.8.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
11.8.3 Kang Yusheng Information Technology Co. Ltd. Computer-aided Drug Discovery (CADD) Introduction
11.8.4 Kang Yusheng Information Technology Co. Ltd. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.8.5 Kang Yusheng Information Technology Co. Ltd. Recent Development
11.9 OpenEye Scientific Software Inc.
11.9.1 OpenEye Scientific Software Inc. Company Detail
11.9.2 OpenEye Scientific Software Inc. Business Overview
11.9.3 OpenEye Scientific Software Inc. Computer-aided Drug Discovery (CADD) Introduction
11.9.4 OpenEye Scientific Software Inc. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.9.5 OpenEye Scientific Software Inc. Recent Development
11.10 Pharmaron Beijing Co. Ltd.
11.10.1 Pharmaron Beijing Co. Ltd. Company Detail
11.10.2 Pharmaron Beijing Co. Ltd. Business Overview
11.10.3 Pharmaron Beijing Co. Ltd. Computer-aided Drug Discovery (CADD) Introduction
11.10.4 Pharmaron Beijing Co. Ltd. Revenue in Computer-aided Drug Discovery (CADD) Business (2018-2023)
11.10.5 Pharmaron Beijing Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Aaranya Biosciences Pvt. Ltd.
Albany Molecular Research Inc.
Charles River Laboratories International Inc.
ChemBio Discovery Inc.
Chemical Computing Group ULC
CompChem Solutions Ltd.
IBM
Kang Yusheng Information Technology Co. Ltd.
OpenEye Scientific Software Inc.
Pharmaron Beijing Co. Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂